CA9 and renal cell carcinoma: To demonstrate the specific killing activity of fully human anti-CAIX mAbs against CAIX-expressing cells, we engineered the rapidly growing CAIX-negative RCC cell line SKRC-59 to stably express human CAIX (CAIX+ SKRC-59) by lentiviral transduction.